SCHEMBL26112457

SCHEMBL26112457

CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(O)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 4/20 0.88
▸ CNR2 P34972 3/20 0.88
▸ FAAH O00519 4/20 0.78
▸ EPHX2 P34913 3/20 0.78
▸ TRPV1 Q8NER1 3/20 0.75
▸ PSMB11 A5LHX3 1/20 0.67
▸ PSMA7 O14818 1/20 0.67
▸ PSMB1 P20618 1/20 0.67
▸ PSMA1 P25786 1/20 0.67
▸ PSMA2 P25787 1/20 0.67
▸ PSMA3 P25788 1/20 0.67
▸ PSMA4 P25789 1/20 0.67
▸ PSMB8 P28062 1/20 0.67
▸ PSMB9 P28065 1/20 0.67
▸ PSMA5 P28066 1/20 0.67
▸ PSMB4 P28070 1/20 0.67
▸ PSMB6 P28072 1/20 0.67
▸ PSMB5 P28074 1/20 0.67
▸ PSMB10 P40306 1/20 0.67
▸ PSMB3 P49720 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31659455 0.97 CNR1 (0.92) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7271387 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7264157 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7200728 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7271203 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7199890 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7262778 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7262773 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL10532438 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1
SCHEMBL7268946 0.92 EPHX2 (0.74) CNR1CNR2FAAHEPHX2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250230125-A1 Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-07-17 — — US disclosed
CN-119677506-A Small molecule allosteric modulators of serotonin (5-HT) 5-HT2C and 5-HT2A receptors 得克萨斯系统大学董事会 2025-03-21 — — CN disclosed
EP-4504164-A1 SMALL MOLECULE ALLOSTERIC MODULATORS OF THE SEROTONIN (5-HT) 5-HT2C AND 5-HT2A RECEPTORS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-02-12 — — EP disclosed
WO-2023191951-A1 SMALL MOLECULE ALLOSTERIC MODULATORS OF THE SEROTONIN (5-HT) 5-HT2C AND 5-HT2A RECEPTORS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230125-A1 Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors HTR2C, HTR2A, HTR5A CNR1 119/4885CNR2 52/4885FAAH 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback